Get the Stockscreener App
0.7524
3.98%
-0.0312
Citius Oncology Inc Stock (CTOR) Forecast
The Citius Oncology Inc (CTOR) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.5067, representing a -32.65% decrease from the current price of $0.7524. The highest analyst price target is $0.8952, and the lowest is $0.1183.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CTOR Price Target
Average 2.6319
(+249.80% Upside)
Is Citius Oncology Inc (CTOR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.25 | Neutral |
| STOCH(9,6) | 10.60 | Buy |
| STOCHRSI(14) | 2.4979 | Buy |
| MACD(12,26) | -0.0315 | Sell |
| ADX(14) | 29.11 | Sell |
| William %R | -97.44 | Buy |
| CCI(14) | -89.15 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.834
Sell
|
0.8354
Sell
|
| MA20 |
0.9387
Sell
|
0.8757
Sell
|
| MA50 |
0.8665
Sell
|
0.8595
Sell
|
| MA100 |
0.7763
Sell
|
0.8453
Sell
|
| MA200 |
0.8606
Sell
|
0.9947
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CTOR could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CTOR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.25 indicates that CTOR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.6 indicates that CTOR is oversold. This indicates that CTOR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 2.4979 indicates that CTOR is oversold. This suggests that CTOR price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.11 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -89.15 indicates that CTOR is still oversold but not to an extreme extent.
Long-term CTOR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Citius Oncology Inc financial reports and earnings history, Citius Oncology Inc (CTOR) stock could reach $1.2264 by 2030, $2.1691 by 2040 and $6.8839 by 2050. See the projected annual prices until 2050 of the Citius Oncology Inc stock below:
- Citius Oncology Inc (CTOR) is expected to reach an average price of $2.2859 in 2035, with a high prediction of $2.9034 and a low estimate of $2.6659. This indicates an $203.81% rise from the last recorded price of $0.7524.
- Citius Oncology Inc (CTOR) stock is projected to chart a bullish course in 2040, with an average price target of $2.6404, representing an $250.93% surge from its current level. The forecast ranges from a conservative $1.2451 to a sky-high $2.1691.
- Our analysts predict Citius Oncology Inc (CTOR) to jump 596.35% by 2045, soaring from $5.0356 to an average price of $5.2394, potentially reaching $4.9294. While $5.0356 is the low estimate, the potential upside is significant.
- Citius Oncology Inc (CTOR) stock is expected to climb by 2050, reaching an average of $6.6127, a $778.88% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.8839 and $6.7805, respectively, highlighting the market's uncertainty.
Citius Oncology Inc Stock (CTOR) Year by Year Forecast
Citius Oncology Inc Stock (CTOR) Price Forecast for 2026
The predicted value for Citius Oncology Inc (CTOR) in 2026 is set at an average of $0.8568. Estimates vary from a peak of $1.6536 to a trough of $0.0601, indicating an +13.88% surge from the present price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.2183 | $0.1183 | $0.8952 | -70.99% |
| December, 2026 | $0.0814 | $0.0601 | $0.2641 | -89.18% |
Citius Oncology Inc Stock (CTOR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Citius Oncology Inc (CTOR) is $2.6319, with a high forecast of $5.2626 and a low forecast of $0.00126. This indicates an +249.80% increase from the last price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.1345 | $0.00126 | $0.2545 | -82.12% |
| February, 2027 | $0.3276 | $0.0997 | $1.2176 | -56.45% |
| March, 2027 | $0.2165 | $0.0292 | $0.3033 | -71.22% |
| April, 2027 | $0.1407 | $0.0423 | $0.5623 | -81.31% |
| May, 2027 | $0.0914 | $0.0628 | $0.2939 | -87.85% |
| June, 2027 | $0.0783 | $0.2188 | $0.271 | -89.59% |
| July, 2027 | $0.2562 | $0.3652 | $0.2698 | -65.95% |
| August, 2027 | $0.0463 | $0.0954 | $0.0852 | -93.85% |
| September, 2027 | $1.6968 | $0.0807 | $2.4968 | +125.52% |
| October, 2027 | $1.9099 | $1.4426 | $5.2626 | +153.84% |
| November, 2027 | $0.9288 | $0.4457 | $1.7605 | +23.45% |
| December, 2027 | $1.0219 | $0.7004 | $1.3324 | +35.83% |
Citius Oncology Inc Stock (CTOR) Price Forecast for 2028
In 2028, Citius Oncology Inc (CTOR) is projected to reach an average price of $0.7191, with a high projection of $1.4324 and a low estimate of $0.00576. This indicates an -4.43% fall from the last price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.0608 | $0.8335 | $1.2651 | +41.00% |
| February, 2028 | $0.944 | $0.7682 | $1.4324 | +25.46% |
| March, 2028 | $0.5871 | $0.2813 | $0.9397 | -21.97% |
| April, 2028 | $0.3702 | $0.167 | $1.0529 | -50.80% |
| May, 2028 | $0.3991 | $0.196 | $0.5175 | -46.96% |
| June, 2028 | $0.4522 | $0.3111 | $0.5464 | -39.90% |
| July, 2028 | $0.1671 | $0.0667 | $0.473 | -77.79% |
| August, 2028 | $0.2221 | $0.00576 | $0.2642 | -70.48% |
| September, 2028 | $0.2742 | $0.1609 | $0.3514 | -63.56% |
| October, 2028 | $0.0603 | $0.0563 | $0.3601 | -91.99% |
| November, 2028 | $0.0998 | $0.0178 | $0.1728 | -86.74% |
| December, 2028 | $0.0394 | $0.0433 | $0.1667 | -94.76% |
Citius Oncology Inc Stock (CTOR) Price Forecast for 2029
The 2029 price forecast for Citius Oncology Inc Stock (CTOR) is $0.6463 on average, with a high prediction of $1.2909 and a low estimate of $0.00178. This represents an -14.10% decrease from the previous price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.2346 | $0.00178 | $0.3891 | -68.82% |
| February, 2029 | $0.5445 | $0.2017 | $0.6445 | -27.63% |
| March, 2029 | $0.3012 | $0.2601 | $0.6302 | -59.96% |
| April, 2029 | $0.7566 | $0.5528 | $0.5966 | +0.55% |
| May, 2029 | $1.1503 | $0.865 | $0.9447 | +52.89% |
| June, 2029 | $1.1091 | $1.1641 | $1.1501 | +47.41% |
| July, 2029 | $1.3172 | $1.1425 | $1.1778 | +75.06% |
| August, 2029 | $1.15 | $1.1932 | $1.10 | +52.85% |
| September, 2029 | $0.8738 | $1.0165 | $0.9585 | +16.14% |
| October, 2029 | $0.916 | $0.9362 | $0.8037 | +21.75% |
| November, 2029 | $1.4198 | $0.9745 | $1.2909 | +88.70% |
| December, 2029 | $1.3101 | $1.2271 | $1.2665 | +74.12% |
Citius Oncology Inc Stock (CTOR) Price Forecast for 2030
Citius Oncology Inc Stock (CTOR) is expected to reach an average price of $2.1738 in 2030, with a high forecast of $4.3352 and a low forecast of $0.0123. This signifies an +188.91% surge from the last price of $0.7524.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.0837 | $1.1207 | $1.2264 | +44.04% |
| February, 2030 | $0.8394 | $1.0255 | $0.9792 | +11.56% |
| March, 2030 | $2.5067 | $0.5152 | $4.3352 | +233.17% |
| April, 2030 | $0.4245 | $0.0355 | $4.0582 | -43.58% |
| May, 2030 | $0.0108 | $0.0223 | $0.5361 | -98.57% |
| June, 2030 | $0.067 | $0.0123 | $0.4685 | -91.09% |
| July, 2030 | $0.0648 | $0.0348 | $0.6148 | -91.39% |
| August, 2030 | $0.3389 | $0.0436 | $0.3264 | -54.95% |
| September, 2030 | $0.1412 | $0.483 | $0.3427 | -81.24% |
| October, 2030 | $0.3949 | $0.4249 | $0.4165 | -47.51% |
| November, 2030 | $0.3087 | $0.4083 | $0.3134 | -58.97% |
| December, 2030 | $0.5685 | $0.3056 | $0.3609 | -24.44% |
7.19%
10.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):